Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Dipti Nakti"'
Autor:
Leena Shah, Amit Janu, Kumar Prabhash, Srushti Shah, Vijay Patil, Smruti Mokal, Dipti Nakti, Amit Joshi, Rahul Ravind, Abhishek Mahajan, Akhil Kapoor, Vanita Noronha, Nandini Menon
Publikováno v:
Acta Oncologica. 59:1520-1527
BACKGROUND There are limited data on the role of chemotherapy in patients with small cell lung cancer (SCLC) and poor performance status (PS). METHODS This was a retrospective analysis of a prospective observational study in patients with SCLC and PS
Autor:
Abhijith Rajaram Rao, Anant Ramaswamy, Sharath Kumar, Shreya Gattani, Ratan Dhekale, Jyoti Krishnamurthy, Sarika Mahajan, Anuradha Daptardar, Jayita Deodhar, Manjunath Nookala, Supriya Goud, Sucheta More, Dipti Nakti, Chetan Mudliya, Nandini Sharrel Menon, Vijay Maruti Patil, Vikram Gota, Shripad Dinanath Banavali, Kumar Prabhash, Vanita Noronha
Publikováno v:
Journal of Clinical Oncology. 40:e24012-e24012
e24012 Background: ASCO guidelines recommend that geriatric assessment (GA) should be performed in all older adults with cancer. However, GA is labor- and time-intensive, hence the uptake is poor, especially in crowded resource poor-settings. There a
Autor:
Vanita Noronha, Vijay Maruti Patil, Nandini Sharrel Menon, Ajaykumar Singh, Sunil Ramdhan Chopade, Amit Janu, Nilendu Purandare, Rajeev Kumar, Supriya Goud, Sucheta More, Srushti Shah, Reshma Vairage, Akanksha Yadav, Dipti Nakti, Chetan Mudliya, Saurabh Kamble, Shital Chavan, Sonali Sonawane, Shripad Dinanath Banavali, Kumar Prabhash
Publikováno v:
Journal of Clinical Oncology. 40:4065-4065
4065 Background: Patients with advanced esophageal/gastroesophageal junction (GEJ) cancer have a dismal outcome. No study has unequivocally proven that systemic chemotherapy prolongs survival. Current NCCN guidelines recommend palliative/best support
Autor:
Abhijith Rajaram Rao, Anant Ramaswamy, Sharath Kumar, Shreya Gattani, Ratan Dhekale, Jyoti Krishnamurthy, Sarika Mahajan, Anuradha Daptardar, Jayita Deodhar, Manjunath Nookala, Supriya Goud, Sucheta More, Dipti Nakti, Chetan Mudliya, Nandini Sharrel Menon, Vijay Maruti Patil, Vikram Gota, Shripad Dinanath Banavali, Kumar Prabhash, Vanita Noronha
Publikováno v:
Journal of Clinical Oncology. 40:e24011-e24011
e24011 Background: Frail older patients present with increased symptom burden, medical complexity and reduced tolerance to medical and surgical interventions. Data regarding the prevalence of frailty and its association with outcomes, such as overall
Autor:
Neha Mittal, Anbarasan Sekar, Suman Kumar, Swapnil Rane, Rup Jyoti Sarma, Amit Kumar Choudhary, Tanmoy Mandal, George Abraham, Kumar Prabhash, Vanita Noronha, Nilendu Purandare, Vijay Patil, Laxma Reddy, Abhishek Mahajan, Keshav Garg, Nandini Menon, Sobin V. Jacob, Dipti Nakti, Munita Bal, Nilesh Sable
Publikováno v:
Indian J Surg Oncol
The real-world patterns of TKI use in differentiated thyroid cancer (DTC) are largely governed by the accessibility and financial feasibility of the patient with more sorafenib use compared to lenvatinib. There are limited data available on the toxic
Autor:
Dipti Nakti, Sobin V. Jacob, Nilesh Sable, Munita Bal, Rup Jyoti Sarma, Vijay Patil, Abhishek Mahajan, Kumar Prabhash, Laxma Reddy Mekala, George Abraham, Neha Mittal, Keshav Garg, Aditya Pavan Kumar Kanteti, Nandini Menon, Suman Kumar, Vanita Noronha, Nilendu Purandare, Tanmoy Mandal, Anbarasan Sekar, Swapnil Rane
Publikováno v:
Indian J Surg Oncol
There is a paucity of evidence of the impact of sorafenib on MCT and it is the preferred therapy used in India. We decided to do an audit of all patients of MCT who were referred to us for systemic therapy. The objective of this exercise was to ident
Autor:
Vanita Noronha, Shripad Banavali, Sudeep Gupta, Shalaka Marfatia, Supriya Goud, Vijay Patil, Sachin Punatar, Sucheta More, Dipti Nakti, Amit Joshi, Purvish M. Parikh, Kumar Prabhash
Publikováno v:
Asia-Pacific Journal of Clinical Oncology. 14:e129-e137
We aimed to find the optimal route of iron supplementation in patients with malignancy and iron deficiency (true or functional) anemia not receiving erythropoiesis stimulating agents (ESA).Adult patients with malignancy requiring chemotherapy, hemogl
Autor:
Sucheta More, Rajiv Kumar, Jai Prakash Agarwal, Kumar Prabhash, Amit Janu, Srushti Shah, Supriya Goud, Dipti Nakti, Shripad Banavali, Vanita Noronha, Amit Joshi, Vijay Patil, Sadhana Kannan, Nandini Menon, Naveen Mummudi, Akanksha Yadav, Abhishek Mahajan, Anil Tibdewal
Publikováno v:
Journal of Clinical Oncology. 39:163-163
163 Background: In RTOG 85-01, patients with locally advanced esophageal and gastroesophageal junction (GEJ) cancer treated with concurrent chemoradiotherapy (CRT) had a median overall survival (OS) of 14 months and 5-year OS of 27%. Improving outcom
Autor:
Vijay Patil, Bhavesh Bandekar, Sabita Jiwnani, Amit Joshi, Nilendu Purandare, Dipti Nakti, Vanita Noronha, Sarbani Ghosh-Laskar, Kumar Prabhash
Publikováno v:
Journal of Gastrointestinal Cancer. 47:294-304
Esophageal cancer with tracheobronchial involvement (TBI) has a poor prognosis. Radical therapy carries the risk of inducing tracheoesophageal fistula (TEF) and treatment-related mortality. Induction chemotherapy followed by reassessment for radical
Autor:
Shaesta Mehta, Arvind Sahu, Prachi Patil, Vijay Patil, Nilendu Purandare, Srushti Shah, Nirmala A. Jambhekar, Sarbani Ghosh-Laskar, Dipti Nakti, Kumar Prabhash, Abhishek Mahajan, Vanita Noronha, Sanjay Talole, Amit Joshi
Publikováno v:
Oncology Research
There are little data on the efficacy and safety of taxane/platinum with definitive radiotherapy (RT) for esophageal/GEJ cancer. This article is a retrospective analysis of patients who received weekly paclitaxel 50 mg/m2 and carboplatin AUC 2 with r